EUVIMEDОткрийте EUVIMED
Übersichtsarbeit

Hormonal male contraception

Christina Wang, Maria Cristina Meriggiola iD, Hermann M Behre, Stephanie T Page

Andrology · 2024

DOI: 10.1111/andr.13699 ↗

At a glance

Übersichtsarbeit in Andrology, 2024. Written by Christina Wang and 3 co-authors. Institution: Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center, and Clinical and Translational Science Institute, The Lundquist Instit…. Major MEDLINE topics: Testosterone, Contraceptive Agents, Male. Cited 10 times so far (Crossref); 55 references.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Introduction

Male contraception with exogenously administered hormones suppresses both luteinizing hormone and follicle stimulating hormone leading to low intratesticular testosterone concentration. This results in reversible suppression of spermatogenesis and marked decrease in sperm output in the ejaculate and preventing pregnancy in the female partner. Prior Studies Studies of testosterone administered alone or in combination of another gonadotropin suppressive agent such as a progestin or gonadotropin releasing hormone (GnRH) analog showed decisively that the exogenous hormone administrations are effective in suppressing sperm output with few adverse events that are not anticipated. In contraceptive efficacy studies, testosterone alone or combined with a progestin are as effective in preventing pregnancies as female contraceptive methods.

Conclusion

Hormone combinations for male contraception are in late‐phase clinical trials and hold the promise of being the new, reversible contraception method for men in over half a century. Lessons learned from the male hormonal contraceptive development pave the way for new targeted approached to regulate male fertility.

Subjects

MeSH terms (MEDLINE)

TestosteroneContraceptive Agents, MaleHumansMaleHormonal ContraceptionSpermatogenesisFemaleContraceptive Agents, HormonalProgestins

Author keywords

gonadotropin releasing hormone analogsmodified androgensprogestinspermatogenesis suppressiontestosterone

Substances

TestosteroneContraceptive Agents, MaleContraceptive Agents, HormonalProgestins

Authors and institutions

  • Division of Endocrinology, Department of Medicine, Harbor-UCLA Medical Center, and Clinical and Translational Science Institute, The Lundquist Institute, Torrance, California, USA.
  • Division of Gynecology and Human Reproduction Physiopathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Center for Reproductive Medicine and Andrology, University Medicine Halle, Halle, Germany.
  • Division of Metabolism, Endocrinology and Nutrition, UW Medicine Diabetes Institute, University of Washington School of Medicine, Seattle, Washington, USA.

ORCID profiles: Maria Cristina Meriggiola

Cite

APA

Wang, C., Meriggiola, M. C., Behre, H. M., & Page, S. T. (2024). Hormonal male contraception. Andrology. https://doi.org/10.1111/andr.13699

Vancouver

Wang C, Meriggiola MC, Behre HM, Page ST. Hormonal male contraception. Andrology. 2024. doi:10.1111/andr.13699

BibTeX
@article{Wang2024,
  author = {Wang, Christina and Meriggiola, Maria Cristina and Behre, Hermann M and Page, Stephanie T},
  title = {Hormonal male contraception},
  journal = {Andrology},
  year = {2024},
  doi = {10.1111/andr.13699}
}
Start for free →